Unearthing Tomorrow's Medicine

In this episode we spoke to Jackie Hunter, CEO of Benevolent Bio, a company that utilises machine learning and AI to find previously overlooked drug candidates within the research literature. Jackie was previously Chief Executive of the BBSRC and comes into the AI space with a wealth of experience in industrial drug discovery.